Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Preliminary results regarding 85 patients of the INTENSIVE study have been published in 2021.
Conference:
Presenting Author: Gervaso L
Authors: Fazio N, Gervaso L, Halfdanarson T, Sonbol M, Pusceddu S,
Keywords: neuroendocrine, NEN, COVID-19, SARS-CoV-2,
#3417 SARS-CoV-2 vaccination site as possible pitfall on somatostatin receptor imaging
Introduction: SARS-CoV-2 (COVID19) vaccinations have shown high efficacy. Therefore, increased chances exist that patients undergoing Peptide Receptor Radionuclide Therapy (PRRT) or radionuclide imaging for Neuroendocrine Tumors (NETs) may have being recently vaccinated.
Conference:
Presenting Author: Kolade O
Authors: Kolade O, Ayeni A, Brink A, Steyn R, Prasad V,
Keywords: COVID-19, SARS-CoV-2, Lu-177 DOTATATE, Ga-68 DOTANOC, Vaccination, PRRT, Neuroendocrine Tumor,
Introduction: The importance of timely assistance in oncological patients is undeniable; however it is well known that these patients could have important clinical problems if they were infected by COVID-19, with an increased risk of severe illness and mortality. A recent multicenter Italian study reported a delay both in the beginning of PRRT for new patients and in those ones who had already started the treatment, as a direct consequence of COVID-19.
Conference:
Presenting Author: Grana C
#3311 Clinical management of neuroendocrine neoplasms (NENs) in the time of COVID-19
Introduction: The current SARS-CoV-2 virus epidemic is an exceptional global health situation, very serious for already fragile patients such as cancer patients. These patients are at much higher risk (4 to5 times) of severe respiratory complications, which develop very quickly, especially since they will have received surgery or chemotherapy in the preceding weeks, putting their vital prognosis at risk, in addition to the risk of cancer «double jeopardy».
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Bengueddach A, Kehili H, Kaid M, Bereksi Reguig F, Tidjene A,
Keywords: COVID-19, SARS-CoV-2, neuroendocrine,
#3254 COVID-19 in patients with neuroendocrine tumors (NETs): The Mayo Clinic experience
Introduction: Coronavirus Disease 2019 (COVID-19) has been associated with increased morbidity and mortality in cancer patients. NETs are rare and there is paucity of data about COVID-19 outcomes.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Rakshit S
Authors: Rakshit S, Lee K, Kendi A, Sonbol M, Starr J,
Keywords: neuroendocrine tumor, covid-19, outcomes, mortality,